Clinical Trials Study
Copyright ©The Author(s) 2024.
World J Cardiol. Mar 26, 2024; 16(3): 149-160
Published online Mar 26, 2024. doi: 10.4330/wjc.v16.i3.149
Table 2 Cardiac magnetic resonance parameters of chamber size, function, epicardial adipose tissue volume of the obesity in populations with and without heart failure with preserved ejection fraction
CMR parameters
HFpEF+ (n = 17)
HFpEF- (n = 45)
P value
Conventional parameters
LVEF (%)0.60 ± 0.030.64 ± 0.010.0797
LV mass index (g/m2)61.38 ± 4.5552.68 ± 1.400.0181a
LVEDD (mm)52.74 ± 1.8050.20 ± 0.570.0833
LVMWT (mm)10.32 ± 0.409.66 ± 0.250.1765
LVEDVi (mL/m2)74.00 ± 5.5269.16 ± 1.720.2716
LVESVi (mL/m2)32.12 ± 5.8724.84 ± 0.780.0592
LA AP diameter (mm)41.37 ± 1.5342.15 ± 0.870.6518
LA LR diameter (mm)67.85 ± 2.5570.63 ± 1.180.2686
Epicardial adipose tissue
EAT volume (mL)160.00 ± 7.13139.80 ± 5.390.0449a
EATi (mL/m2)74.20 ± 3.1665.37 ± 2.230.0360a
EAT mass (g)147.20 ± 6.56128.60 ± 4.980.0451a
EAT mass index (g/m2)68.26 ± 2.9160.10 ± 2.060.0359a
EAT/LA AP diameter ratio3.56 ± 0.183.11 ± 0.140.0843
EAT/LA LR diameter ratio2.19 ± 0.111.84 ± 0.080.0203a
EAT/LV mass ratio1.21 ± 0.091.17 ± 0.060.7737
EAT/LV volume ratio0.99 ± 0.080.92 ± 0.040.4158